@inproceedings{inproceedings, title  = {{Phase I study of ascending doses of the cytotoxic immunoconjugate CMB-401 (hCTMO1-calicheamicin) in patients with epithelial ovarian cancer.}},

 url = {{}},

 year = {{1998}},

 month = {{2}},

 author = {{Gillespie AM and Broadhead TJ and Chan SY and Owen J and Farnsworth AP and Sopwith M and Coleman RE}},

 volume = {{78}},

 journal = {{BRIT J CANCER}},

 pages = {{20-20}},

 note = {{Accessed on 2025/10/10}}}